Sep 06, 2016 7:00am EDT Recro Pharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Jul 26, 2016 4:05pm EDT Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam